Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

The official patch notes for Season 5 of Call of Duty: Black Ops 6 and Warzone have been released, detailing a number of ...

BOISE, Idaho & CHICAGO & NEW YORK & LONDON & HONG KONG, August 06, 2025--Clearwater Analytics Holdings, Inc. (NYSE: CWAN) ...

Three presentations at ADA 2025 highlighted the therapeutic potential of icovamenib across multiple aspects of metabolic health:In patients with type 2 diabetes (T2D) not achieving glycemic targets, ...

Mallinckrodt plc and Endo, Inc. today announced that they have completed their merger to create a global, scaled, diversified therapeutics leader.

Euronext to launch voluntary share exchange offer for all ATHEX shares Euronext announces the submission of a voluntary share exchange offer to acquire all shares of HELLENIC EXCHANGES-ATHEX STOCK EXC ...

Euronext to launch voluntary share exchange offer for all ATHEX shares ...

Takeda ( TSE:4502/NYSE:TAK) today announced that all primary and secondary endpoints were met in two Phase 3 randomized, double-blind, placebo-controlled studies of oveporexton (TAK-861), a potential ...

Detailed price information for Ikena Oncology Inc (IKNA-Q) from The Globe and Mail including charting and trades.